Related Experiment Video
Updated: Oct 21, 2025

Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients
Published on: September 25, 2018
Can cytology reliably subtype non-small cell lung carcinomas?
Deepali Jain1, Lukas Bubendorf2
1Department of Pathology, All India Institute of Medical Sciences, New Delhi, India.
Cytology specimens aid lung cancer diagnosis and subtyping. Accurate subtyping of non-small cell lung cancer (NSCLC) into adenocarcinoma and squamous cell carcinoma is crucial for personalized medicine, though challenges remain in cytology preparations.
Area of Science:
- Oncology
- Cytopathology
Background:
- Cytology specimens are vital for lung cancer diagnosis and predictive testing.
- Accurate subtyping of non-small cell lung cancer (NSCLC) is essential for personalized cancer therapy.
Purpose of the Study:
- To review current concepts, advances, and challenges in subtyping NSCLC using cytology specimens.
- To highlight the importance of accurate morphological and immunocytochemical analysis in NSCLC subtyping.
Main Methods:
- Review of existing literature on NSCLC subtyping in cytology.
- Discussion of diagnostic techniques including morphology, immunocytochemistry, and different specimen types (FNA, exfoliative, cell block).
Main Results:
- Cytology specimens, including fine needle aspiration (FNA), exfoliative cytology, and cell blocks, are reliable for NSCLC diagnosis and subtyping.
- Immunocytochemistry enhances diagnostic accuracy when morphology alone is insufficient, particularly in non-cell block preparations.
Conclusions:
- Subtyping NSCLC in cytology is critical for guiding personalized treatment strategies.
- While morphology is informative, immunocytochemistry is often necessary for definitive subtyping, especially in challenging cases.
More Related Videos
07:59Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
10:29Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
Published on: August 14, 2019